GGrantIndex
← Leaderboards

Jungsu Kim

Mayo Clinic Jacksonville

$16,880,599
Attributed
$16,880,599
Total exposure
9
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3.4M · FY201625
$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,880,599 · 9

By mechanism

R01$13,733,648 · 6
RF1$2,284,811 · 1
R21$862,140 · 2

Top collaborators

No co-investigators on record.

Most similar at Mayo Clinic Jacksonville

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposNeuronsS DiseaseInsightMouse ModelBrainAmyloid Beta-ProteinPathway InteractionsPathogenesisAffectGenesIn VitroGenetic Risk FactorReportingMediatingMicrogliaIn VivoPlayS Disease RiskExperimental StudyPathologicProteinsAbeta ClearanceSenile Plaques

Grant awards (31)

Molecular genetic analyses of transcriptional dysregulation in Alzheimers disease$718,236
R01 · FY2025 · AG · contact PI
The role of ABI3 in Alzheimers disease$699,885
R01 · FY2025 · AG · contact PI
The role of ABI3 in Alzheimers disease$609,442
R01 · FY2025 · AG · contact PI
The role of ABI3 in Alzheimers disease$719,698
R01 · FY2024 · AG · contact PI
The role of ABI3 in Alzheimers disease$698,918
R01 · FY2024 · AG · contact PI
Molecular genetic analyses of transcriptional dysregulation in Alzheimers disease$654,976
R01 · FY2024 · AG · contact PI
The role of ABI3 in Alzheimers disease$755,690
R01 · FY2023 · AG · contact PI
Molecular genetic analyses of transcriptional dysregulation in Alzheimers disease$755,633
R01 · FY2023 · AG · contact PI
The role of ABI3 in Alzheimers disease$760,128
R01 · FY2022 · AG · contact PI
Molecular genetic analyses of transcriptional dysregulation in Alzheimers disease$726,908
R01 · FY2022 · AG · contact PI
The role of ABI3 in Alzheimers disease$2,284,811
RF1 · FY2021 · AG · contact PI
The role of ABI3 in Alzheimers disease$731,915
R01 · FY2021 · AG · contact PI
Generation of Abi3 conditional knockout mouse model$431,765
R21 · FY2021 · AG · contact PI
Role of LDLR in regulating metabolism of Apolipoprotein E and Amyloid-beta$393,750
R01 · FY2020 · AG · contact PI
The role of aging-associated microRNAs in Alzheimer's disease$393,750
R01 · FY2020 · AG · contact PI
Role of microRNA-33 in Alzheimer's disease$389,738
R01 · FY2020 · AG · contact PI
Role of microRNA-33 in Alzheimer's disease$395,458
R01 · FY2019 · AG · contact PI
The role of aging-associated microRNAs in Alzheimer's disease$393,750
R01 · FY2019 · AG · contact PI
Role of LDLR in regulating metabolism of Apolipoprotein E and Amyloid-beta$393,750
R01 · FY2019 · AG · contact PI
Role of microRNA-33 in Alzheimer's disease$393,971
R01 · FY2018 · AG · contact PI
Role of LDLR in regulating metabolism of Apolipoprotein E and Amyloid-beta$391,250
R01 · FY2018 · AG · contact PI
The role of aging-associated microRNAs in Alzheimer's disease$391,250
R01 · FY2018 · AG · contact PI
Role of microRNA-33 in Alzheimer's disease$393,461
R01 · FY2017 · AG · contact PI
The role of aging-associated microRNAs in Alzheimer's disease$391,250
R01 · FY2017 · AG · contact PI
Role of LDLR in regulating metabolism of Apolipoprotein E and Amyloid-beta$391,250
R01 · FY2017 · AG · contact PI
microRNA-758-3p in cognition and Alzheimer's Disease$98,595
R21 · FY2017 · AG · contact PI
microRNA-758-3p in cognition and Alzheimer's disease$97,030
R21 · FY2017 · AG · contact PI
Role of microRNA-33 in Alzheimer's disease$407,091
R01 · FY2016 · AG · contact PI
The role of aging-associated microRNAs in Alzheimer's disease$391,250
R01 · FY2016 · AG · contact PI
Role of LDLR in regulating metabolism of Apolipoprotein E and Amyloid-beta$391,250
R01 · FY2016 · AG · contact PI
microRNA-758-3p in cognition and Alzheimer's disease$234,750
R21 · FY2016 · AG · contact PI